Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Si-Bone Inc (SIBN)

Si-Bone Inc (SIBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 663,769
  • Shares Outstanding, K 41,694
  • Annual Sales, $ 138,890 K
  • Annual Income, $ -43,340 K
  • EBIT $ -46 M
  • EBITDA $ -44 M
  • 60-Month Beta 1.22
  • Price/Sales 4.60
  • Price/Cash Flow N/A
  • Price/Book 3.83

Options Overview Details

View History
  • Implied Volatility 55.25% ( -10.98%)
  • Historical Volatility 61.68%
  • IV Percentile 41%
  • IV Rank 48.12%
  • IV High 94.60% on 04/29/24
  • IV Low 18.76% on 05/23/24
  • Put/Call Vol Ratio 0.15
  • Today's Volume 38
  • Volume Avg (30-Day) 591
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 6,014
  • Open Int (30-Day) 5,495

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.22
  • Number of Estimates 5
  • High Estimate -0.20
  • Low Estimate -0.25
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.05 +29.71%
on 10/28/24
16.18 -3.40%
on 11/12/24
+2.50 (+19.04%)
since 10/11/24
3-Month
12.05 +29.71%
on 10/28/24
17.31 -9.73%
on 08/26/24
+1.54 (+10.93%)
since 08/12/24
52-Week
11.76 +32.91%
on 06/25/24
21.70 -27.97%
on 12/26/23
-0.12 (-0.76%)
since 11/10/23

Most Recent Stories

More News
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SIBN : 15.63 (-1.82%)
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Graniteâ„¢

SIBN : 15.63 (-1.82%)
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

SIBN : 15.63 (-1.82%)
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SIBN : 15.63 (-1.82%)
Why Shares of Si-Bone Jumped Tuesday

The company reported first-quarter earnings and improved revenue guidance.

SIBN : 15.63 (-1.82%)
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022

SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal...

SIBN : 15.63 (-1.82%)
SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022

SANTA CLARA, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...

SIBN : 15.63 (-1.82%)
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System

Use Includes Pelvic Fragility Fractures...

SIBN : 15.63 (-1.82%)
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology

SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving...

SIBN : 15.63 (-1.82%)
SI-BONE, Inc. Reports First Quarter 2022 Financial Results

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal...

SIBN : 15.63 (-1.82%)

Business Summary

SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.

See More

Key Turning Points

3rd Resistance Point 16.99
2nd Resistance Point 16.58
1st Resistance Point 16.11
Last Price 15.63
1st Support Level 15.23
2nd Support Level 14.82
3rd Support Level 14.35

See More

52-Week High 21.70
Fibonacci 61.8% 17.90
Fibonacci 50% 16.73
Last Price 15.63
Fibonacci 38.2% 15.56
52-Week Low 11.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar